z-logo
open-access-imgOpen Access
How Should We Manage Renal Transplant Patients with Failed Allografts Who Return to Dialysis?
Author(s) -
Guneet S. Kochar,
Anthony Langone
Publication year - 2020
Publication title -
blood purification
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 57
eISSN - 1421-9735
pISSN - 0253-5068
DOI - 10.1159/000505284
Subject(s) - medicine , dialysis , immunosuppression , intensive care medicine , population , end stage renal disease , disease , quality of life (healthcare) , bilateral nephrectomy , transplantation , peritoneal dialysis , surgery , kidney , nephrectomy , environmental health , nursing
Patients with failing renal allografts often progress to end-stage renal disease, unlike transplant-naive chronic kidney disease patients, in an accelerated and unpredictable manner. The variability of this population renders decisions regarding placement of permanent dialysis access more difficult. Since patients with failed allografts who return to dialysis experience higher rates of morbidity and mortality, recognition and optimization of factors that will improve survival outcomes and quality of life are tantamount to longer term success. We provide guidelines on several topics such as immunosuppression withdrawal and determination of nephrectomy need versus retaining the allograft based on the current literature and our copious single-center experience.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom